245 related articles for article (PubMed ID: 26762742)
1. Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
Lim C; Sung M; Shepherd FA; Nouriany N; Sawczak M; Paul T; Perera-Low N; Foster A; Zawisza D; Feld R; Liu G; Leighl NB
J Thorac Oncol; 2016 Jan; 11(1):79-84. PubMed ID: 26762742
[TBL] [Abstract][Full Text] [Related]
2. A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry.
McCoach CE; Berge EM; Lu X; Barón AE; Camidge DR
J Thorac Oncol; 2016 Mar; 11(3):407-13. PubMed ID: 26725180
[TBL] [Abstract][Full Text] [Related]
3. Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.
Spiegel ML; Goldman JW; Wolf BR; Nameth DJ; Grogan TR; Lisberg AE; Wong DJL; Ledezma BA; Mendenhall MA; Genshaft SJ; Gutierrez AJ; Abtin F; Wallace WD; Adame CR; McKenzie JR; Abarca PA; Li AJ; Strunck JL; Famenini S; Carroll JM; Tucker DA; Sauer LM; Moghadam NM; Elashoff DA; Abaya CD; Brennan MB; Garon EB
Cancer; 2017 Dec; 123(24):4800-4807. PubMed ID: 29125624
[TBL] [Abstract][Full Text] [Related]
4. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
[TBL] [Abstract][Full Text] [Related]
5. Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials.
Baggstrom MQ; Waqar SN; Sezhiyan AK; Gilstrap E; Gao F; Morgensztern D; Govindan R
J Thorac Oncol; 2011 Jan; 6(1):98-102. PubMed ID: 21150469
[TBL] [Abstract][Full Text] [Related]
6. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer.
Cooke DT; Gandara DR; Goodwin NC; Calhoun RF; Lara PN; Mack PC; David EA
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):36-40. PubMed ID: 24746995
[TBL] [Abstract][Full Text] [Related]
8. Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.
Kitazono S; Fujiwara Y; Tsuta K; Utsumi H; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Sasada S; Watanabe S; Asamura H; Tamura T; Ohe Y
Clin Lung Cancer; 2015 Sep; 16(5):385-90. PubMed ID: 25937270
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.
Tam AL; Kim ES; Lee JJ; Ensor JE; Hicks ME; Tang X; Blumenschein GR; Alden CM; Erasmus JJ; Tsao A; Lippman SM; Hong WK; Wistuba II; Gupta S
J Thorac Oncol; 2013 Apr; 8(4):436-42. PubMed ID: 23442309
[TBL] [Abstract][Full Text] [Related]
10. The challenge of molecular testing for clinical trials in advanced non-small cell lung cancer patients: Analysis of a prospective database.
Vrancken A; Lepers S; Peeters L; Oyen C; Dooms C; Nackaerts K; Verbeken E; Wauters I; Weynand B; Vansteenkiste J
Lung Cancer; 2016 Dec; 102():96-100. PubMed ID: 27987596
[TBL] [Abstract][Full Text] [Related]
11. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
[TBL] [Abstract][Full Text] [Related]
12. Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
Baty F; Facompré M; Kaiser S; Schumacher M; Pless M; Bubendorf L; Savic S; Marrer E; Budach W; Buess M; Kehren J; Tamm M; Brutsche MH
Am J Respir Crit Care Med; 2010 Jan; 181(2):181-8. PubMed ID: 19833826
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
[TBL] [Abstract][Full Text] [Related]
14. Study design issues and early stage non-small cell lung cancer.
Schiller JH
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5030s-5032s. PubMed ID: 16000609
[TBL] [Abstract][Full Text] [Related]
15. Does intensive follow-up alter outcome in patients with advanced lung cancer?
Benamore R; Shepherd FA; Leighl N; Pintilie M; Patel M; Feld R; Herman S
J Thorac Oncol; 2007 Apr; 2(4):273-81. PubMed ID: 17409797
[TBL] [Abstract][Full Text] [Related]
16. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
17. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
Watanabe S; Asamura H; Suzuki K; Tsuchiya R
Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
Di Maio M; Signoriello S; Morabito A; Rossi A; Maione P; Piantedosi F; Bilancia D; Cigolari S; Barbera S; Gebbia V; Daniele B; Robbiati SF; Illiano A; Ceribelli A; Carrozza F; Favaretto A; Piazza E; Piccirillo MC; Daniele G; Giordano P; Costanzo R; Sandomenico C; Rocco G; Gallo C; Perrone F; Gridelli C
Lung Cancer; 2012 Jun; 76(3):457-64. PubMed ID: 22297086
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
20. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
